Researchers from the School of Biomedical Sciences at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), have made a significant advancement that could reshape the treatment landscape for hepatocellular carcinoma (HCC), the most common type of liver cancer, which often resists treatment and recurs. This cancer is especially prevalent in Southeast Asia and China. The research, published in the journal Science Translational Medicine [link to publication], revealed a previously unknown mechanism that allows HCC to grow more aggressively and evade existing therapies. The team also developed a new small molecule inhibitor that could improve treatment options for HCC patients.
A HKUMed research co-led by Professor Stephanie Ma Kwai-yee (first left) and Professor Clive Chung Yik-sham (first right), paves the way for significant advancement in hepatocellular carcinoma (HCC) treatment by identifying a key protein that fuels tumour growth and developing an inhibitor that can improve treatment outcomes.
Unravelling the mystery of tumour resistance
The liver plays a crucial role in various metabolic functions. In HCC, cancerous cells significantly alter these metabolic processes fuelling tumour growth. ‘In our study, we found that a specific metabolic pathway helps cancer cells maintain their stemness, which refer to their enhanced ability to grow, spread and survive,’ explained Professor Stephanie Ma Kwai-yee, co-lead author of the study, and Jimmy and Emily Tang Professor in Molecular Genetics in the School of Biomedical Sciences at HKUMed. Professor Ma is also Associate Vice-President (Research and Innovation) at HKU.
This pathway involves a protein called AGPAT4, which is abundant in both embryonic stem cells and HCC tumour cells, but is rarely found in normal tissues. ‘Our data show that AGPAT4 acts like a switch that makes cancer cells more flexible and aggressive,’ said Professor Ma. ‘This flexibility, known as tumour plasticity, is linked to a higher chance of the cancer to recur, spread and resist existing treatments like sorafenib, a widely used drug for liver cancer.’
The research team discovered that AGPAT4 increases the conversion of a fat molecule called LPA (lysophosphatidic acid) into another molecule called PA (phosphatidic acid). This process activates a signalling pathway involving cell manager mTOR and other proteins, which promote tumour growth and survival. Professor Ma added, ‘When we blocked AGPAT4 in a mouse model, tumour growth slowed down and the cancer became more sensitive to sorafenib.’
HKUMed researchers have identified key protein in liver cancer resistance and developed inhibitor to enhance therapy and prevent cancer recurrence. The research is co-led by Professor Stephanie Ma Kwai-yee (second right) and Professor Clive Chung Yik-sham (first right).
Developing an inhibitor to target AGPAT4
Building on these findings, the team developed a compound called CL26, which specifically targets AGPAT4. In preclinical models using patient-derived tumours, CL26 worked in combination with sorafenib to significantly suppress tumour growth. Toxicological assessments showed minimal side effects, suggesting the compound may be safe for future clinical use.
‘This is a promising step forward,’ said Professor Clive Chung Yik-sham, Assistant Professor in the School of Biomedical Sciences, HKUMed, who also co-led the study. ‘CL26 allows us to target liver cancer cells with precision, potentially improving outcomes for patients who no longer respond to standard treatments.’
Eyes on clinical trials to validate treatment potential
‘Our research suggests that AGPAT4 helps HCC cancer cells become more adaptable and resistant to therapy,’ said Professor Ma. ‘By targeting this protein, we may enhance the effectiveness of sorafenib and expand the therapeutic options for patients in clinical settings. We aim to offer hope to countless patients battling this challenging disease.’Professor Chung added, ‘CL26’s ability to precisely target AGPAT4 is likely one of the key reasons it works so well. We are conducting larger-scale preclinical studies to further assess the efficacy and safety of CL26 and hope to advance to investigational new drug studies and clinical trials.’
About the research team
The collaborative study was co-led by Professor Stephanie Ma Kwai-yee and Professor Clive Chung Yik-sham from the School of Biomedical Sciences at HKUMed. The co-first authors were Dr Johnson Ng Kai-yu and Amy Koo Tin-yan. Major collaborators included professors from The Hong Kong Polytechnic University, the Fourth Military Medical University in Xi’an, the Sun Yat-sen University Cancer Centre, and Guangzhou Medical University in Guangzhou; and Professor Guan Xinyuan from the Department of Clinical Oncology of the School of Clinical Medicine at HKUMed.
Acknowledgements
This research was funded by various grants from the Hong Kong Research Grants Council, including the Theme-Based Research Scheme, the Research Impact Fund, the Collaborative Research Fund, the General Research Fund, the Early Career Scheme and the Research Fellow Scheme. Additional support was provided by the Croucher Foundation’s Senior Research Fellowship and the Guangdong Science and Technology Department. The project also received separate grants through the Innovation and Technology Support Programme under the Innovation and Technology Fund, as well as funding for the Laboratory for Synthetic Chemistry and Chemical Biology, the Centre for Oncology and Immunology, and the Centre for Translational and Stem Cell Biology under the Health@InnoHK Programme initiated by the Innovation and Technology Commission of the HKSAR Government
LIMA, Peru (AP) — Pope Leo XIV bid farewell to his beloved second homeland of Peru on Monday with an “hasta luego,” after a marathon 12-day South American tour that tested his stamina after lung cancer surgery.
During the traditional popemobile ride before Leo's final Mass, someone threw an apparent rosary toward the pope that seemed to hit him in the face. The pope winced and touched his temple, but he proceeded on and the Mass began as planned. The Vatican said some 1.5 million people attended.
The faithful often toss rosaries, stuffed animals, sports jerseys and other items towards the popemobile and Leo has often wowed the crowd with his quick reflexes in catching them. His bodyguards, though, have lamented that such tossed objects are among their chief concerns in protecting the pope when he is out in public.
For the Chicago-born Leo, who spent two decades in Peru as a missionary priest and bishop, the trip was an emotional homecoming to a place that he has credited with teaching him how to be a shepherd. Upon arrival, he declared that Peru was his “patria” or homeland, and he sang the national anthem alongside President Keiko Fujimori. Leo has American and Peruvian citizenship.
“It was here that you taught me how to be a bishop, and this time I learned a little more about serving as the Successor of Peter,” Leo said at the end of Mass as many in the crowd knelt on the dirt ground to receive his final blessing.
“I have felt at home, and you have reminded me that the Church truly is a family,” he said.
Over the course of the trip, it became clear that Leo modeled his ministry in Peru and now for the universal Catholic Church on the figure of the first archbishop of Lima, St. Turibius of Mogrovejo.
Mogrovejo, who lived from 1538-1606, is revered for having denounced abuses against Indigenous and enslaved people by Spanish colonizers. He is also remembered for having crisscrossed his vast diocese on foot and horseback to minister to his flock, learning Quechua and Aymara to better preach to its Indigenous members and overseeing the translation of church teachings so they could understand.
Following his example, Leo traveled across Peru to where the Catholic hierarchy rarely goes to minister to his flock, going high up in the Andes mountains and deep into the Amazon rainforest and points in between. On his final full day in Peru on Sunday, Leo went from his former diocese of Chiclayo on the north Pacific coast to the southeastern Andean city of Cusco, to the northeastern Amazonian city of Pucallpa and back to Lima on the coast.
The climatic and altitude changes alone were exhausting — from hot, humid Chiclayo to chilly and rainy Cusco (at an oxygen-challenging altitude of 3,400 meters or about 11,150 feet) to the steaming heat of the Pucallpa rainforest and back to the gray humidity of Lima.
It was a daylong lesson in what it means to be a shepherd. But it also served to say “So there!” to the nay-sayers, including some in the Vatican who had questioned whether Leo would have to change the course of his pontificate given his lung cancer diagnosis.
On Monday, Leo proceeded with his program as planned and made clear he wasn't saying “adiós” or goodbye forever to Peru.
Speaking to the crowd outside the Vatican residence, Leo thanked Peruvians for having accompanied him on his trip. “Have a good day, thank you very much, and until later!” he said.
At the home for the elderly in Callao, where Leo visited with residents, Leo bid farewell again saying “hasta pronto, hasta luego,” another way of saying “see you soon.”
Callao Mayor César Pérez told The Associated Press that Father Roberto, as he is known to the Peruvian people, would drive approximately 12 hours from Chiclayo in northern Peru to Callao during the pandemic because he wanted to ensure the well-being of older residents.
Leo delivered food and other supplies to the home but didn't enter the facility in order to protect the residents from the virus, Pérez said.
The Peru stop capped a visit that began on Nov. 6 in Uruguay and proceeded on to Argentina, the homeland of Leo’s predecessor Pope Francis, who never returned during his pontificate.
The trip itself was in doubt after Leo underwent lung cancer surgery Oct. 13 in Rome. But Leo said as the visit began that he had “no doubt” that he would make it.
Rosa María Flores, who was attending Leo's final Mass, was glad he did. She said the most important thing about the pope’s visit was that he brought faith to the people of his homeland of Peru.
“We have so much crime, so many deaths; we’re in great need of peace, reconciliation and faith,” she said. “I know that he’s pouring blessings on Peru and that things will get better for all of us.”
Some people at the Mass complained they couldn’t hear the pope because the giant TV screens didn’t work. Others begged firefighters to spray them with water to cool off, and the firefighters obliged.
One of the most meaningful visits for Leo was to the sanctuary of Mogrovejo in the city of Zaña in the diocese of Chiclayo. Leo revealed that he had come there the night before he was ordained a bishop to pray, so important to him was the saint who died there after falling ill during one of his own missionary visits.
“This is a kneeling place for Robert Prevost,” the Rev. David Farfan, the parish pastor, told AP. Many of the pope’s actions, he said, “helping people in the world, as a peacemaker, he did them while also kneeling in this sacred place because a saint passed away here.”
Associated Press religion coverage receives support through the AP’s collaboration with The Conversation US, with funding from Lilly Endowment Inc. The AP is solely responsible for this content.
Pope Leo XIV arrives to preside over Mass at Las Palmas Air Base in Lima, on the eleventh day of his twelve-day apostolic journey to South America, Monday, Nov. 16, 2026. (AP Photo/Andrew Medichini)
Pope Leo XIV arrives to preside over Mass at Las Palmas Air Base in Lima, on the eleventh day of his twelve-day apostolic journey to South America, Monday, Nov. 16, 2026. (AP Photo/Andrew Medichini)
Nuns wait Pope Leo XIV for a visit to the staff and residents of a shelter run by the Little Sisters for abandoned elderly people in Callao, Peru, on the eleventh day of his twelve-day apostolic journey to South America, Monday, Nov. 16, 2026. (Tiziana Fabi/Pool Photo via AP)
Pope Leo XIV visits the staff and residents of a shelter run by the Little Sisters for abandoned elderly people in Callao, Peru, on the eleventh day of his twelve-day apostolic journey to South America, Monday, Nov. 16, 2026. (Tiziana Fabi/Pool Photo via AP)
Pope Leo XIV leaves a meeting with the faithful and representatives of popular devotion at Saqsaywaman National Archaeological Park in Cusco, Peru, on the tenth day of his twelve-day apostolic journey to South America, Sunday, Nov. 15, 2026. (AP Photo/Andrew Medichini)
Pope Leo XIV arrives to preside over Mass at Las Palmas Air Base in Lima, on the eleventh day of his twelve-day apostolic journey to South America, Monday, Nov. 16, 2026. (AP Photo/Andrew Medichini)
Pope Leo XIV grimaces as he touches his face upon arriving to celebrate Mass at Las Palmas Air Base in Lima, Peru, Monday, Nov. 16, 2026. (AP Photo/Silvia Izquierdo)